|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 12919 |
FusionGeneSummary for FANCD2_CIDECP |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FANCD2_CIDECP | Fusion gene ID: 12919 | Hgene | Tgene | Gene symbol | FANCD2 | CIDECP | Gene ID | 2177 | 152302 |
| Gene name | FA complementation group D2 | cell death-inducing DFFA-like effector c pseudogene | |
| Synonyms | FA-D2|FA4|FACD|FAD|FAD2|FANCD | CICE | |
| Cytomap | 3p25.3 | 3p25.3 | |
| Type of gene | protein-coding | pseudo | |
| Description | Fanconi anemia group D2 proteinFanconi anemia complementation group D2 | cell death-inducing CIDE-like effector pseudogene | |
| Modification date | 20180523 | 20180329 | |
| UniProtAcc | Q9BXW9 | ||
| Ensembl transtripts involved in fusion gene | ENST00000287647, ENST00000383807, ENST00000383806, ENST00000419585, ENST00000431693, ENST00000438741, | ENST00000432401, | |
| Fusion gene scores | * DoF score | 5 X 5 X 4=100 | 2 X 2 X 2=8 |
| # samples | 6 | 2 | |
| ** MAII score | log2(6/100*10)=-0.736965594166206 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
| Context | PubMed: FANCD2 [Title/Abstract] AND CIDECP [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | FANCD2 | GO:0010332 | response to gamma radiation | 12874027 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BLCA | TCGA-K4-A3WU-01B | FANCD2 | chr3 | 10070405 | + | CIDECP | chr3 | 10059755 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000287647 | ENST00000432401 | FANCD2 | chr3 | 10070405 | + | CIDECP | chr3 | 10059755 | - |
| 5CDS-intron | ENST00000383807 | ENST00000432401 | FANCD2 | chr3 | 10070405 | + | CIDECP | chr3 | 10059755 | - |
| 5CDS-intron | ENST00000383806 | ENST00000432401 | FANCD2 | chr3 | 10070405 | + | CIDECP | chr3 | 10059755 | - |
| 5CDS-intron | ENST00000419585 | ENST00000432401 | FANCD2 | chr3 | 10070405 | + | CIDECP | chr3 | 10059755 | - |
| 5CDS-intron | ENST00000431693 | ENST00000432401 | FANCD2 | chr3 | 10070405 | + | CIDECP | chr3 | 10059755 | - |
| intron-intron | ENST00000438741 | ENST00000432401 | FANCD2 | chr3 | 10070405 | + | CIDECP | chr3 | 10059755 | - |
Top |
FusionProtFeatures for FANCD2_CIDECP |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FANCD2 | CIDECP |
| Required for maintenance of chromosomal stability.Promotes accurate and efficient pairing of homologs duringmeiosis. Involved in the repair of DNA double-strand breaks, bothby homologous recombination and single-strand annealing. Mayparticipate in S phase and G2 phase checkpoint activation upon DNAdamage. Plays a role in preventing breakage and loss ofmissegregating chromatin at the end of cell division, particularlyafter replication stress. Required for the targeting, orstabilization, of BLM to non-centromeric abnormal structuresinduced by replicative stress. Promotes BRCA2/FANCD1 loading ontodamaged chromatin. May also be involved in B-cell immunoglobulinisotype switching. {ECO:0000269|PubMed:11239453,ECO:0000269|PubMed:11239454, ECO:0000269|PubMed:12086603,ECO:0000269|PubMed:12239151, ECO:0000269|PubMed:14517836,ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15314022,ECO:0000269|PubMed:15377654, ECO:0000269|PubMed:15454491,ECO:0000269|PubMed:15650050, ECO:0000269|PubMed:15661754,ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:19465921}. | Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FANCD2_CIDECP |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FANCD2_CIDECP |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| FANCD2 | TNFRSF1A, TNFRSF1B, ATM, BLM, BRCA2, NBN, MEN1, BRCA1, FANCE, KAT5, USP1, RAD18, TNKS, TERF1, POLN, CEBPD, IPO4, FAN1, FOXO3, H2AFX, PCNA, FANCI, DCLRE1B, FANCG, ATR, FANCC, MYC, MDC1, ELAVL1, MSH2, MLH1, UBC, FANCL, POLH, CDK20, DNM1, IRF2BPL, DCP2, FZR1, RBBP8, TNFSF13B, CA14, P2RY8, PTGER3, ALDH3A2, KPNA1, NTRK1, MUS81, FBXW7, UBE2T, CDC42, EPHA2, HNRNPD, YEATS4, JRKL, EMC2, ITGB3BP, PIGS, CNTROB, BAG6, RAD51, REV1, CDC5L, POU5F1, CHEK1, TPTE, LPAR4, FANCA, CTBP1, RUNX3, RUNX1, DNA2, BRIP1, LAMB2, MCM2, MCM3, MCM4, HELQ, ATP5A1, PRKDC, ERCC4, RPA1, SLX4, PARP1, PARP2, TOP3A, SPTAN1, SPTA1, AKT1, MCM6, MCM5, MCM7, HIST1H3A, HIST1H4A, HIST1H2AB, HIST1H2BB, ABCB6, UHRF2 | CIDECP |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FANCD2_CIDECP |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for FANCD2_CIDECP |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | FANCD2 | C0015625 | Fanconi Anemia | 1 | CTD_human;ORPHANET |
| Hgene | FANCD2 | C3160738 | FANCONI ANEMIA, COMPLEMENTATION GROUP D2 | 1 | CTD_human;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|